Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient

ConditionAging
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-65
SponsorIBSA Farmaceutici Italia Srl

About this trial

Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population.

Eligibility criteria

Qualifiers

Informed consent as documented by signature

Male or female

Age 55-65 years, inclusive

In good general health as evidenced by medical history and current health status

Disqualifiers

Body Mass Index < 18.5 or ≥ 30

Difficulty in swallowing (dysphagia)

Known allergy or sensitivity to any ingredient of the study intervention

Any medical condition or clinically significant abnormalities in laboratory values (hematology, blood chemistry, urinalysis) at screening which in the judgment of the Investigator makes the subject unsuitable for the study

Trial design

Treatments tested in this trial

  • Salvia haenkei 175mg
  • Salvia haenkei 350mg

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators